Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: Med Care. 2018 Dec;56(12):e90–e96. doi: 10.1097/MLR.0000000000000877

Table 1.

Frequency of SEER-Medicare Patients Diagnosed with Cancer, 2004–2013, with an MDS Assessment 2011–2014, by Cancer Site

2011 2012 2013 2014 2011–2014 % of all SEER-Medicare patients matched to MDS*
Patients Newly Admitted to a NH All Patients in a NH Patients Newly Admitted to a NH All Patients in a NH Patients Newly Admitted to a NH All Patients in a NH Patients Newly Admitted to a NH All Patients in a NH Patients Newly Admitted to a NH All Patients in a NH
Bladder 4,420 6,077 3,731 6,372 3,307 6,349 2,632 5,721 14,090 17,092 20.17
Breast 10,986 15,950 8,975 16,831 8,334 17,454 7,749 17,589 36,044 44,536 14.17
Colorectal 9,866 14,429 7,684 14,513 6,724 14,158 4,211 11,165 28,485 35,782 21.13
Kidney 2,534 3,443 2,077 3,646 1,813 3,617 1,302 3,171 7,726 9,422 17.13
Leukemias 1,981 2,795 1,534 2,704 1,376 2,624 969 2,145 5,860 7,214 18.32
Lung 10,348 14,211 7,917 13,339 6,855 12,291 3,370 7,353 28,490 35,686 24.03
Non-hodgkin lymphoma 3,394 4,577 2,774 4,701 2,698 4,843 1,847 4,059 10,713 12,985 18.33
Ovary 1,009 1,381 788 1,336 708 1,268 412 910 2,917 3,624 19.18
Pancreas 1,819 2,490 1,385 2,307 1,114 1,966 363 772 4,681 5,967 22.30
Prostate 8,925 12,522 7,777 13,625 7,811 14,728 7,371 15,164 31,884 39,241 10.53
Thyroid 587 824 549 921 517 1,000 464 984 2,117 2,578 9.14
Uterus/Endometrium 2,453 3,485 1,993 3,644 1,934 3,782 1,515 3,505 7,895 9,693 15.51
Other cancers 22,556 31,908 17,881 32,216 16,079 31,602 10,685 25,037 67,201 84,020 19.06
Multiple cancers 2,761 3,779 2,416 4,014 2,224 4,108 1,443 3,270 8,844 10,777 19.39
TOTAL 83,639 117,871 67,481 120,169 61,494 119,790 44,333 100,845 256,947 318,617 16.88

Note. NH=nursing home; SEER= Surveillance, Epidemiology and End Results; MDS= Minimum Data Set;

*

Percent figures are calculated for the subgroup of SEER-Medicare patients who were alive on January 1, 2011